<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ870403-0110 </DOCNO><HL> U.S. Healthcare Inc. Drug Unit</HL><DD> 04/03/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> USHC WNEWS </IN><DATELINE> BLUE BELL, Pa.  </DATELINE><TEXT>   U.S. Healthcare Inc. said it will invest $10 million to form a pharmaceutical unit to develop drugs to treat cancer.    The operator of health maintenance organizations said the venture won't dilute its earnings. Initially, the unit will supply generic drugs for certain of its HMO members, the company said.    Dr. Philip S. Schein, clinical professor of medicine and pharmacology at Georgetown University, will serve as president and chief executive officer of the new unit. </TEXT></DOC>